Animal model of mania induced by ouabain: Evidence of oxidative stress in submitochondrial particles of the rat brain

Neurochemistry International

Volumn 55, Issue 7, 2009, Pages 491-495

  Riegel, Rafael E ^a   Valvassori, Samira S ^a   Elias, Guilherme ^a   Réus, Gislaine Z ^a   Steckert, Amanda V ^a   de Souza, Bruna ^a   Petronilho, Fabrícia ^a   Gavioli, Elaine C ^a   Dal Pizzol, Felipe ^a   Quevedo, João ^a  

^a Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina   (Brazil)

Author keywords

Bipolar disorder; Mania; Mitochondrial dysfunction; Ouabain; Oxidative stress; Rat

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); OUABAIN; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; BRAIN MITOCHONDRION; CORPUS STRIATUM; HIPPOCAMPUS; HYPOTHESIS; LOCOMOTION; MALE; MANIA; MOUSE; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL;

ANIMALS; BIPOLAR DISORDER; BRAIN CHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MALE; MITOCHONDRIA; MOTOR ACTIVITY; OUABAIN; OXIDATIVE STRESS; RATS; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; SUPEROXIDES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; RATTUS; STROPHANTHUS GRATUS;

EID: 69549111432     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.05.003     Document Type: Article

References (42)

1. Adleman N.E., Barnea-Goraly N., and Chank K.D. Review of magnetic resonance imaging and spectroscopy studies in children with bipolar disorder. Exp. Rev. Neurotherap. 4 (2004) 69-77
2. Altshuler L.L., Bartzokis G., Grieder T., Curran J., Jimenez T., Leight K., Wilkins J., Gerner R., and Mintz J. An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol. Psychiatry 48 (2000) 147-162
3. Baldessarini R.J., and Tondo L. Suicide risk and treatments for patients with bipolar disorder. JAMA 290 (2003) 1517-1519
4. Brambilla P., Harenski K., Nicoletti M., Sassi R.B., Mallinger A.G., Frank E., Kupfer D.J., Keshavan M.S., and Soares J.C. MRI investigation of temporal lobe structures in bipolar patients. J. Psychiatr. Res. 37 (2003) 287-295
5. Boveris A., Oshino N., and Chance B. The cellular production of hydrogen peroxide. Biochem. J. 128 (1972) 617-627
6. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol. 105 (1984) 429-435
7. Calabrese V., Scapagnini G., Giuffrida Stella A.M., Bates T.E., and Clark J.B. Mitochondrial involvement in brain function and dysfunction: relevance to aging neurodegenerative disorders and longevity. Neurochem. Res. 26 (2001) 739-764
8. Clark J.B. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev. Neurosci. 20 (1998) 271-276
9. Decker S., Grider G., and Cobb M. Open field is more sensitive that automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model for bipolar illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 24 (2000) 455-462
10. Einat H., Yuan P., Gould T.D., Li J., Du J., Manji H.K., and Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood regulation. J. Neurosci. 23 (2003) 7311-7316
11. El-Mallakh R.S., Decker S., Morris M., Li X.P., Huff M.O., El-Masri M.A., and Levy R.S. Efficacy of olanzapine and haloperidol in an animal model of mania. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 1261-1264
12. El-Mallakh R.S., El-Masri M.A., Huff M.O., Li X.P., Decker S., and Levy R.S. Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disorder 5 (2003) 362-365
13. El-Mallakh R.S., and Wyatt R.J. The Na, K-ATPase hypothesis for bipolar illness. Biol. Psychiatry 37 4 (1995) 235-244
14. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186 (1990) 407-421
15. Frey B.N., Valvassori S.S., Gomes K.M., Martins M.R., Dal-Pizzol F., Kapczinski F., and Quevedo J. Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res. 1097 (2006) 224-229
16. Iwamoto K., Bundo M., and Kato T. Altered expression of mitochondria-related genes in post mortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 14 (2005) 241-253
17. Kato T. The role of mitochondrial dysfunction in bipolar disorder. Drug News Perspect. 19 10 (2006) 597-602
18. Kato T., and Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disorder 2 (2000) 180-190
19. Kunz M., Gama C.S., Andreazza A.C., Salvador M., Ceresér K.M., Gomes F.A., Belmonte-de-Abreu P.S., Berk M., and Kapczinski F. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 1677-1681
20. Lai J.C., Walsh J.M., Dennis S.C., and Clark J.B. Synaptic and nonsynaptic mitochondria from rat brain: isolation and characterization. J. Neurochem. 28 (1977) 625-631
21. Lees G.J. Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res. Brain Res. Rev. 16 (1991) 283-300
22. Looney S.W., and El-Mallakh R.S. Meta-analysis of erythrocyte Na, K-ATPase activity in bipolar illness. Depress. Anxiety 5 (1997) 53-65
23. Lopez A.D., and Murray C.C. The global burden of disease. Nat. Med. 4 (1998) 1241-1243
24. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
25. Machado-Vieira R., Schmidt A.P., Avila T.T., Kapczinski F., Soares J.C., Souza D.O., and Portela L.V. Increased cerebrospinal fluid levels of S100B protein in rat model of mania induced by ouabain. Life Sci. 76 (2004) 805-811
26. Manji H.K., and Chen G. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol. Psychiatry 7 (2002) S46-S56
27. Mattiasson G. Analysis of mitochondrial generation and release of reactive oxygen species. Cytometry A 62 (2004) 89-96
28. Munakata K., Iwamoto K., Bundo M., and Kato T. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol. Psychiatry 57 (2005) 525-532
29. Osby U., Brandt L., Correia N., Ekbom A., and Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch. Gen. Psychiatry 58 (2001) 844-850
30. Quiroz J.A., Gray N.A., Kato T., and Manji H.K. Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33 (2008) 2551-2565
31. Reddy P.L., Khanna S., and Subhash M.N. Erythrocyte membrane sodium-potassium adenosine triphosphatase activity in affective disorders. J. Neural Transm. Gen. Sect. 89 (1992) 209-218
32. Rezin G.T., Amboni G., Zugno A.I., Quevedo J., and Streck E.L. Mitochondrial dysfunction and psychiatric disorders. Neurochem. Res. 34 (2009) 1021-1029
33. Ruktanonchai D.J., El-Mallakh R.S., Li R., and Levy R.S. Persistent hyperactivity following a single intracerebroventricular dose of ouabain. Physiol. Behav. 63 (1998) 403-406
34. Sims N.R. Selective impairment of respiration in mitochondria isolated from brain subregions following transient forebrain ischemia in the rat. J. Neurochem. 56 (1991) 1836-1844
35. Sonnewald U., Hertz L., and Schousboe A. Mitochondrial heterogeneity in the brain at the cellular level. J. Cereb. Blood Flow Metab. 18 (1998) 231-237
36. Stork C., and Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 10 (2005) 900-919
37. Strakowski S.M., DelBello M.P., Sax K.W., Zimmerman M.E., Shear P.K., Hawkins J.M., and Larson E.R. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch. Gen. Psychiatry 56 (1999) 254-260
38. Strakowski S.M., DelBello M.P., and Adler C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol. Psychiatry 10 (2005) 105-116
39. Sullivan P.G., Rabchevsky A.G., Keller J.N., Lovell M., Sodhi A., Hart R.P., and Scheff S.W. Intrinsic differences in brain and spinal cord mitochondria: implication for therapeutic interventions. J. Comp. Neurol. 474 (2004) 524-534
40. Tritschler H.-J., Packer L., and Medori R. Oxidative stress and mitochondrial dysfunction in neurodegeneration. Biochem. Mol. Biol. Int. 34 (1994) 169-181
41. Vianna M.R., Alonso M., Violo H., Quevedo J., De-Paris F., Furman M., de Stein M.L., Medina J.H., and Izquierdo I. Role of hippocampal signaling pathways in long-term memory formation of nonassociative learning task in the rat. Learn. Memory 7 (2000) 333-340
42. Zarate Jr. C.A., Singh J., and Manji H.K. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol. Psychiatry 59 (2006) 1006-1020